EFSCE
ALXN

Enterprise Financial Services Corp (EFSC)’s Alexion Pharmaceuticals ALXN Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-320
Closed -$59K – 1325
2021
Q2 		$59K Sell
320
-1
-0.3% -$172 0.01% 354
2021
Q1 		$49K Buy
321
+17
+6% +$2.63K 0.01% 410
2020
Q4 		$47K Buy
304
+6
+2% +$771 0.01% 397
2020
Q3 		$34K Hold
298
– – 0.01% 453
2020
Q2 		$33K Buy
298
+223
+297% +$23.7K 0.01% 451
2020
Q1 		$7K Buy
75
+67
+838% +$6.58K ﹤0.01% 740
2019
Q4 		$1K Hold
8
– – ﹤0.01% 1112
2019
Q3 		$1K Buy
8
+5
+167% +$564 ﹤0.01% 1116
2019
Q2 		$0 Hold
3
– – ﹤0.01% 1230
2019
Q1 		$0 Sell
3
-41
-93% -$5.1K ﹤0.01% 1257
2018
Q4 		$4K Hold
44
– – ﹤0.01% 732
2018
Q3 		$6K Hold
44
– – ﹤0.01% 713
2018
Q2 		$5K Buy
44
+41
+1,367% +$4.79K ﹤0.01% 744
2018
Q1 		$0 Hold
3
– – ﹤0.01% 965
2017
Q4 		$0 Hold
3
– – ﹤0.01% 939
2017
Q3 		$0 Hold
3
– – ﹤0.01% 962
2017
Q2 		$0 Sell
3
-90
-97% -$10.5K ﹤0.01% 1083
2017
Q1 		$11K Buy
93
+25
+37% +$3.22K 0.01% 601
2016
Q4 		$8K Buy
68
+38
+127% +$4.65K ﹤0.01% 662
2016
Q3 		$4K Sell
30
-61
-67% -$7.85K ﹤0.01% 782
2016
Q2 		$11K Buy
91
+51
+128% +$7.24K 0.01% 531
2016
Q1 		$6K Sell
40
-67
-63% -$9.84K ﹤0.01% 677
2015
Q4 		$20K Buy
107
+94
+723% +$16.4K 0.01% 395
2015
Q3 		$2K Hold
13
– – ﹤0.01% 944
2015
Q2 		$2K Sell
13
-26
-67% -$4.49K ﹤0.01% 946
2015
Q1 		$7K Buy
39
+17
+77% +$3.08K ﹤0.01% 718
2014
Q4 		$4K Hold
22
– – ﹤0.01% 886
2014
Q3 		$4K Sell
22
-4
-15% -$657 ﹤0.01% 858
2014
Q2 		$4K Sell
26
-18
-41% -$2.84K ﹤0.01% 901
2014
Q1 		$7K Buy
44
+17
+63% +$2.7K ﹤0.01% 735
2013
Q4 		$4K Hold
27
– – ﹤0.01% 856
2013
Q3 		$3K Hold
27
– – ﹤0.01% 931
2013
Q2 		$2K Buy
+27
New +$2.6K ﹤0.01% 884

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s ALXN Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 320 shares — an estimated $59K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $59K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 320 Alexion Pharmaceuticals shares in Q3 2021, an estimated $59K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Alexion Pharmaceuticals position peaked at $59K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.